(20s)-20-hydroxycholesterol has been researched along with gw9662 in 1 studies
| Studies ((20s)-20-hydroxycholesterol) | Trials ((20s)-20-hydroxycholesterol) | Recent Studies (post-2010) ((20s)-20-hydroxycholesterol) | Studies (gw9662) | Trials (gw9662) | Recent Studies (post-2010) (gw9662) |
|---|---|---|---|---|---|
| 51 | 0 | 14 | 617 | 0 | 406 |
| Protein | Taxonomy | (20s)-20-hydroxycholesterol (IC50) | gw9662 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.3 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.086 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunsveld, L; Doveston, RG; Meijer, FA; Sampers, ENR; van den Oetelaar, MCM | 1 |
1 other study(ies) available for (20s)-20-hydroxycholesterol and gw9662
| Article | Year |
|---|---|
Covalent Occlusion of the RORĪ³t Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site.
Topics: | 2021 |